Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease

Aim. To study the efficacy of class IC arrhythmic drugs (AAD) and catheter ablation (CA) for paroxysmal form of atrial fibrillation (AF) in patients with without structural heart disease.Material and methods. The study included 122 patients (44 men, 78 women, mean age 63 [55;68] years) with symptoma...

Full description

Saved in:

Bibliographic Details
Main Authors:	D. A. Tsaregorodtsev, M. A. Khalikova, S. S. Vasyukov, M. M. Beraya, A. V. Sedov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2023-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	atrial fibrillation antiarrhythmic drug therapy lappaconitine hydrobromide propafenone diethylaminopropionylethoxycarbonylaminophenothiazine hydrochloride radiofrequency ablation cryoballoon ablation for atrial fibrillation
Online Access:	https://www.rpcardio.online/jour/article/view/2847
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

Nonfluoroscopic catheter ablation in patients with atrial fibrillation
by: O. V. Sapelnikov, et al.
Published: (2020-12-01)

Prevention of atrial tachyarrhythmia in post-operation period of pulmonary veins ostia catheter isolation in paroxysmal atrial fibrillation
by: A. V. Tarasov, et al.
Published: (2016-10-01)

Cryoballoon versus radiofrequency ablation for persistent atrial fibrillation: an updated systematic review and meta‑analysis
by: Yi-Meng Gao, et al.
Published: (2025-07-01)

Pulsed‐Field Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation: A Systematic Review and Meta‐Analysis
by: Inês Martins Esteves, et al.
Published: (2025-08-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

Differences between 2 cryoballoon systems in achieving successful pulmonary vein isolation in patients with challenging anatomies
by: Shuhei Yamashita, MD, et al.
Published: (2025-08-01)

Value of morphological and laboratory markers in predicting the effectiveness of cryoballoon pulmonary vein isolation in atrial fibrillation
by: E. N. Kalemberg, et al.
Published: (2023-06-01)

COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY
by: A. V. Tarasov, et al.
Published: (2017-03-01)

Different impact of female gender on the outcome of catheter ablation between paroxysmal and persistent atrial fibrillation
by: Wei Du, et al.
Published: (2025-05-01)

Pulsed-field ablation versus cryoballoon ablation in patients with persistent atrial fibrillation
by: Corinne Isenegger, et al.
Published: (2025-08-01)

Posterior wall isolation using the cryoballoon ablation in patients with persistent and long-standing persistent atrial fibrillation
by: A. S. Omelyanenko, et al.
Published: (2025-03-01)

CRYOBALLOON ABLATION IN RUSSIAN SITES OF INTERVENTIONAL ATRIAL FIBRILLATION MANAGEMENT TREATMENT: RESULTS OF THE FIRST NATIONWIDE SURVEY
by: E. N. Mikhailov, et al.
Published: (2015-11-01)

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
by: Yu. A. Bunin, et al.
Published: (2005-12-01)

Myocardial electroporation — an alternative to thermal methods of atrial fibrillation treatment
by: E. A. Archakov, et al.
Published: (2023-07-01)

Pulsed Field Ablation: A Systematic Review
by: Poe Nu Htay, et al.
Published: (2025-05-01)

Catheter ablation of atrial arrhythmias in patients after thoracoscopic ablation of persistent atrial fibrillation
by: E. A. Artyukhina, et al.
Published: (2020-08-01)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016-01-01)

Antithrombotic Therapy in Patients with Paroxysmal Atrial Fibrillation after Catheter Treatment
by: O. R. Eshmatov, et al.
Published: (2023-05-01)

THE PROPANORM EFFICACY IN RAPID RELIEF OF SYMPTOMS OF PAROXYSMAL AURICULAR FIBRILLATION
by: N. N. Borovkov, et al.
Published: (2003-10-01)

Clinical efficacy of atrial fibrillation ablation depending on histological changes in the myocardium
by: A. E. Shelemekhov, et al.
Published: (2020-08-01)

Prediction of difficulty in cryoballoon ablation with a three‐dimensional deep learning model using polygonal mesh representation
by: Kazutaka Nakasone, et al.
Published: (2025-04-01)

Catheter ablation of atrial fibrillation versus antiarrhythmic therapy in patients with left ventricular systolic dysfunction
by: D. F. Ardus, et al.
Published: (2023-05-01)

1C-INDUCED ATRIAL FLUTTER IN A PATIENT WITH WPW SYNDROME: CASE REPORT AND REVIEW
by: R. R. Mamatkazina, et al.
Published: (2015-12-01)

The HALP Index Is Associated with the Recurrence of Persistent Atrial Fibrillation Following Radiofrequency Catheter Ablation
by: Wang Z, et al.
Published: (2025-04-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation
by: I. G. Fomina, et al.
Published: (2005-08-01)

Effectiveness and safety of different types of ablation modalities in patients with atrial fibrillation: a bayesian network meta-analysis from randomized controlled trials
by: Fan Maitri Aldian, et al.
Published: (2025-05-01)

Comparative efficacy and safety of POLARx versus Arctic front advance pro cryoballoon systems for pulmonary vein isolation in atrial fibrillation: an updated systematic review and meta-analysis
by: Muhammad Fawad Tahir, et al.
Published: (2025-08-01)

From fluttering hearts to restless stomach: navigating atrial fibrillation, ablation and gastroparesis
by: Rabia Riasat, et al.
Published: (2025-06-01)

Electroanatomic substrate of atrial fibrillation in patients after COVID-19
by: An. M. Osadchy, et al.
Published: (2021-08-01)

Predictors of atrial fibrillation recurrence in patients with metabolic syndrome after pulmonary vein isolation
by: V. A. Ionin, et al.
Published: (2022-09-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Cryoballoon Ablation of Atrial Fibrillation Through a Permanent Inferior Vena Cava Filter
by: Ippei Saito, et al.
Published: (2025-07-01)

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY
by: R. D. Kurbanov, et al.
Published: (2015-12-01)

Proactive esophageal cooling protects against thermal insults during high-power short-duration radiofrequency cardiac ablation
by: Marcela Mercado Montoya, et al.
Published: (2022-12-01)

Antiarrhythmic drug use in atrial fibrillation among different European countries – as determined by a physician survey
by: Espen Fengsrud, et al.
Published: (2025-08-01)

"Fire or Ice" in the Treatment of Patients with Complex Heart Rhythm Disorders
by: T. R. Ibragimov, et al.
Published: (2019-03-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)